Preclinical Ophthalmotoxicity Studies of Medicinal Products: a Review of Regulatory Approaches and Research Methods
INTRODUCTION. Ophthalmotoxicity assessment of potential drugs is a highly meaningful element of preclinical trials that reflects modes of action and pharmacological effects of a chemical compound on the eyes in topical and systemic use. However, there is no relevant common algorithm for ophthalmotox...
محفوظ في:
| المؤلفون الرئيسيون: | , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Russo |
| منشور في: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2025-12-01
|
| سلاسل: | Безопасность и риск фармакотерапии |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://www.risksafety.ru/jour/article/view/406 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|